Gainers

• INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regular session. The market value of their outstanding shares is at $2.2 million. The company's, Q1 earnings came out 4 days ago.
• Curis (NASDAQ:CRIS) shares moved upwards by 65.64% to $0.34. The company's market cap stands at $8.0 million.
• Shuttle Pharmaceuticals (NASDAQ:SHPH) stock rose 27.77% to $4.83. The company's market cap stands at $2.2 million.
• rYojbaba (NASDAQ:RYOJ) shares moved upwards by 27.04% to $2.65. The market value of their outstanding shares is at $23.4 million.
• Pyxis Oncology (NASDAQ:PYXS) stock rose 24.88% to $2.79. The market value of their outstanding shares is at $141.2 million.
• CalciMedica (NASDAQ:CALC) shares increased by 23.76% to $0.77. The market value of their outstanding shares is at $9.8 million.

Losers

• Creative Medical Tech (NASDAQ:CELZ) stock declined by 33.2% to $1.34 during Friday's regular session. The market value of their outstanding shares is at $7.3 million.
• Omeros (NASDAQ:OMER) stock decreased by 23.23% to $8.23. The company's market cap stands at $775.8 million.
• Icecure Medical (NASDAQ:ICCM) shares declined by 18.24% to $5.74. The market value of their outstanding shares is at $591.0 million.
• Cryo-Cell International (AMEX:CCEL) shares decreased by 18.23% to $3.14. The market value of their outstanding shares is at $30.9 million.
• Regencell Bioscience (NASDAQ:RGC) stock declined by 17.9% to $6.15. The market value of their outstanding shares is at $3.7 billion.
• Atlantic International (NASDAQ:ATLN) shares fell 15.49% to $0.88. The market value of their outstanding shares is at $79.2 million. As per the news, the Q1 earnings report came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.